In recent research, a synthetic peptide called BPC-157 has shown promise in correcting calcium imbalance
doi: 10.1074/jbc.m603670200
Live Vitals clinician-gated model is exactly the right structure for that, but it means availability of specific compounds can change
Nevertheless, although BPC 157 lacks general standard neurotransmitter criteria, a network of interconnected evidence has demonstrated that BPC 157 therapy counteracts, in addition to NO-system disturbances, also dopamine, serotonin, glutamate, GABA, adrenalin/noradrenalin, and acetylcholine disturbances, whether specifically related to their receptors, including both blockade and over-activity, destruction, depletion, tolerance, and sensitization, and there is also channel disturbance counteraction [6,9]